Dalia El‐Gamal

Also affiliated with University of Cincinnati Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma”.

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

iScience(2021)10.1016/j.isci.2021.102931

N/A

0DataRank · unranked

14 citations

Kendra R. Vann, Shweta Joshi, Namood-e Sahar, Guillermo Morales, Dalia El‐Gamal +3 more

Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection

Structure(2022)10.1016/j.str.2022.05.020

N/A

0DataRank · unranked

33 citations

Arpan Acharya, Suk Min Jang, Catherine Lachance, Mohamad Zandian, Tina Holt +8 more

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma

Molecular Biomedicine(2022)10.1186/s43556-021-00066-9

N/A

0DataRank · unranked

12 citations

Dhananjaya Pal, Audrey L. Smith, Namood-e Sahar, Maddeboina Krishnaiah, Dalia El‐Gamal +2 more

Perturbation of the Gut Microbiome and Association with Outcomes Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

medRxiv(2022)10.1101/2022.05.19.22275261

N/A

0DataRank · unranked

4 citations

Sailendharan Sudakaran, Fotis Asimakopoulos, Peiman Hematti, Dalia El‐Gamal, Nasia Safdar +2 more

Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2256914

N/A

0DataRank · unranked

3 citations

Dhananjaya Pal, Rolando Martinez-Rico, Alexandria P. Eiken, Donald L. Durden, Tatiana G. Kutateladze +2 more

High‐grade B‐cell lymphoma not otherwise specified, with diffuse large B‐cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics

American Journal of Hematology(2024)10.1002/ajh.27513

N/A

0DataRank · unranked

13 citations

Alyssa Bouska, Tyler A. Herek, Catalina Amador, Joo Y. Song, Alexander M. Xu +25 more

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity

Scientific Reports(2024)10.1038/s41598-024-65576-2

N/A

0DataRank · unranked

5 citations

Maia M. C. Bennett-Boehm, Frederik Holm Rothemejer, I. Weber, Alexander K. Regan, J. Franzen +11 more

The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax

Hemato(2024)10.3390/hemato5030024

N/A

0DataRank · unranked

2 citations

Elizabeth Schmitz, Erin M. Drengler, Audrey L. Smith, Sydney A. Skupa, Kabhilan Mohan +7 more

Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.31.578283

N/A

0DataRank · unranked

0 citations

Audrey L. Smith, Sydney A. Skupa, Elizabeth Schmitz, Sandeep Rana, Sarbjit Singh +13 more

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

Nature Communications(2025)10.1038/s41467-025-64666-7

N/A

0DataRank · unranked

2 citations

Roshia Ali, Alyssa Bouska, Dylan T. Jochum, Meghana Kesireddy, Simeon Mahov +34 more